Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Retained Earnings (2019 - 2026)

Adagene (ADAG) posted quarterly Retained Earnings of -$328785.0 billion for Q4 2025, down 5.66% year-over-year from -$348507.0 billion in Q4 2024, and down 101272697.48% quarter-over-quarter from -$324.7 million in Q2 2025.

Analysis

Adagene (ADAG) Retained Earnings (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Retained Earnings for 7 consecutive years, with -$328785.0 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Retained Earnings fell 5.66% year-over-year to -$328785.0 billion; the TTM figure through Dec 2025 stood at -$328785.0 billion (down 5.66% YoY), while the FY2025 annual figure was -$328785.0 billion, down 5.66% from the prior year.
  • Retained Earnings declined to -$328785.0 billion in Q4 2025 per ADAG's latest filing, from -$324.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $336.1 million in Q4 2021 and bottomed at -$328785.0 billion in Q4 2025.
  • Historically, Retained Earnings has averaged -$166590.8 billion across 5 years, with a median of -$242640.6 billion in 2022.
  • Annual changes were most pronounced in 2021 — Retained Earnings soared 418.11% — and 2022, when it tumbled 158545499.39%.
  • Adagene's Retained Earnings stood at $336.1 million in 2021, then tumbled by 77002527.59% to -$258805.1 billion in 2022, then decreased by 7.32% to -$277751.5 billion in 2023, then retreated by 12.03% to -$311175.6 billion in 2024, then slipped by 5.66% to -$328785.0 billion in 2025.
  • Business Quant data shows ADAG's Retained Earnings at -$328785.0 billion in Q4 2025, -$324.7 million in Q2 2025, and -$311175.6 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Adagene 211.24 Mn 211.24 Mn - 436.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 436.77 Mn
Dec 31, 2025 366.04 Mn
Jun 30, 2025 364.25 Mn
Dec 31, 2024 362.22 Mn
Jun 30, 2024 352.65 Mn
Dec 31, 2023 350.11 Mn
Jun 30, 2023 346.96 Mn
Dec 31, 2022 342.74 Mn
Jun 30, 2022 342.63 Mn
Dec 31, 2021 336.10 Mn
Jun 30, 2021 329.22 Mn
Dec 31, 2020 23.79 Mn
Dec 31, 2019 6.79 Mn